Trade, Inc.
ENID
Start free

Penta Valent Tbk.

PEVE · Kesehatan · Farmasi & Riset Kesehatan

334

-32.66% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 48

  • Value

    54Against 788 other IDX companies

    Priced about in line with comparable stocks.

    P/E
    10.3×
    68%Cheaper than 68% of other IDX companies
    P/B
    1.56×
    39%Cheaper than 39% of other IDX companies
    Dividend yield
    —
    —Not ranked

  • Quality

    58Against 788 other IDX companies

    About as profitable as comparable stocks.

    Return on equity
    15.2%
    82%Higher than 82% of other IDX companies
    Return on assets
    3.9%
    58%Higher than 58% of other IDX companies
    Net margin
    1.5%
    34%Higher than 34% of other IDX companies

  • Growth

    56Against 788 other IDX companies

    Growing roughly in line with comparable stocks.

    Profit, last 4 quarters
    -1.8%
    43%Higher than 43% of other IDX companies
    Profit, 3-year yearly
    +32.9%
    80%Higher than 80% of other IDX companies
    Profit, latest quarter vs a year ago
    +9.3%
    50%Higher than 50% of other IDX companies
    Revenue, latest quarter vs a year ago
    +14.1%
    52%Higher than 52% of other IDX companies

  • Momentum

    35Against 836 traded stocks

    Has lagged most stocks over the past year.

    1-year price change
    -29.8%
    35%Better than 35% of traded stocks

  • Liquidity

    44Against 836 traded stocks

    Trades about as much as a typical IDX stock.

    Value traded per day, 30 days
    IDR 724M
    44%Higher than 44% of traded stocks

  • Retail penalty

    −1Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 19% of the other stocks where it is, so 1 point comes off the rating.

    Retail average buy
    363
    Close vs that average
    -7.9%
    Retail net bought
    -4K lots

Similar stocks

Rated most like PEVE across the five pillars. Change is over the past year.